Anti-inflammatory · Drug monograph
Phenylbutazone: veterinary dose and monograph
Phenylbutazone is a veterinary anti-inflammatory drug. Pyrazolone NSAID — non-selective COX inhibitor, the workhorse equine musculoskeletal NSAID. Indications include equine musculoskeletal inflammation — lameness, OA, tendinitis, laminitis (chronic phase); equine fever associated with infection (limited use); equine colic — analgesia (less popular than flunixin). This monograph lists 5 reference doses for dogs, cats and horses, each with route, frequency and source.
At a glance
- Drug class
- Anti-inflammatory
- Also known as
- Bute, Butazolidin, Phenylzone
- Species with doses
- Dogs, Cats and Horses
- General dose range
- 2.2–8.8 mg/kg PO q12h × 4–7 d — check the species tables for the indication
- Routes
- PO, IV
- Last reviewed
- 1 October 2026
Indications
- Equine musculoskeletal inflammation — lameness, OA, tendinitis, laminitis (chronic phase)
- Equine fever associated with infection (limited use)
- Equine colic — analgesia (less popular than flunixin)
- Canine OA (historical use — newer NSAIDs preferred)
Phenylbutazone dose by species
Doses are per administration unless stated. mg/kg doses scale with body weight; per-animal, per-quarter and infusion-rate doses are shown as the reference writes them.
Dogs
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Pain / inflammation (Plumb's, historical) | 14 mg/kg | PO | q8h initial then taper | — |
- Pain / inflammation (Plumb's, historical): Plumb’s p.964 (label): 14 mg/kg PO three times daily initially, maximum 800 mg/day regardless of weight, then titrate to the lowest effective dose; 15–22 mg/kg PO q12h (Posner & Papich). Papich 5e: 15–22 mg/kg q8–12h PO or IV (44 mg/kg/day; 800 mg/dog maximum). Plumb’s: little reason to use it now that safer approved NSAIDs exist — bone-marrow suppression risk.
Cats
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Anti-inflammatory (rarely used) | 6–8 mg/kg | PO | q12h | — |
- Anti-inflammatory (rarely used): Papich 5e: cats 6–8 mg/kg q12h IV or PO. Safer approved NSAIDs are preferred; monitor for GI and haematological toxicity.
Horses
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Acute lameness / inflammation | 4.4 mg/kg | PO | q12h | 2–3 days, then taper |
| Maintenance / chronic OA | 2.2 mg/kg | PO | q12h, then q24h | — |
| IV therapy | 2.2–4.4 mg/kg | IV | q24h | 48–96 h (max 5 days) |
- Acute lameness / inflammation: Papich 5e: 4.4–8.8 mg/kg PER DAY (generally 2–4 g per horse) — typically 4.4 mg/kg q12h for the first 2–3 days, tapering to 2.2 mg/kg q12h (1 g per horse) and then once daily; do not use the top dose for more than 48–96 h. Plumb’s p.964 (label): 2–4 g PO per 454 kg per day, never more than 4 g/day. (The previous 8.8 mg/kg q12h doubled the maximum daily dose.)
- Maintenance / chronic OA: Papich 5e: taper to 2.2 mg/kg q12h (≈1 g per horse) and eventually once daily. Plumb’s p.964: osteoarthritis — minimal dose 2.2 mg/kg PO twice daily (Laverty 2008). Use the lowest effective dose; GI ulceration, right dorsal colitis and renal papillary necrosis with chronic use.
- IV therapy: Papich 5e: injection 2.2–4.4 mg/kg/day for 48–96 h, IV only — IM injection causes tissue irritation. Plumb’s p.964 (label): 1–2 g IV per 454 kg, given slowly, for no more than 5 successive days; then oral. Perivascular injection causes severe sloughing.
Contraindications
PROHIBITED in any animal intended for human consumption (food animals — long tissue residence; carcinogenic concerns in humans). Pre-existing GI ulcers, hepatic / renal disease, bone marrow disorders. Hypersensitivity. Dehydration. Dogs: newer COX-2 selective NSAIDs preferred — bute is not recommended in dogs by current standard of care.
Species-specific warnings
Horses: Workhorse equine NSAID. Right dorsal colitis is the catastrophic complication — limit duration, monitor TP and faecal blood.
Cattle: PROHIBITED in food-producing animals — long tissue residence and human carcinogenicity concerns.
Dogs: Largely obsolete — newer COX-2-selective NSAIDs (carprofen, meloxicam, firocoxib) are safer and preferred.
Adverse effects
- GI ulceration — right dorsal colitis in horses (most serious complication; sudden onset diarrhoea / colic / hypoproteinaemia)
- Renal papillary necrosis (especially with dehydration)
- Hepatic toxicity
- Bone marrow suppression (long-term, dogs)
- Oral / oesophageal irritation from undissolved paste / powder
- Hypoproteinaemia / oedema (chronic use)
Drug interactions
- Other NSAIDs (flunixin, ketoprofen): additive GI / renal toxicity — DO NOT combine
- Corticosteroids: additive GI ulceration — DO NOT combine
- Warfarin / oral anticoagulants: phenylbutazone displaces warfarin from albumin → bleeding risk
- Aminoglycosides: additive nephrotoxicity in dehydrated patients
- Furosemide: synergistic renal injury
- Methotrexate: phenylbutazone reduces methotrexate clearance
Pregnancy and lactation
AVOID in pregnancy — fetal prostaglandin synthesis essential for normal cardiac and renal development. Use alternative NSAIDs (flunixin per Plumb's safer profile) or refer if absolutely necessary.
Monitoring
- Serum creatinine / urea — baseline and every 7 days during therapy
- CBC every 14 days for prolonged courses
- Faecal occult blood / clinical GI signs
- Total protein / albumin — drops in right dorsal colitis
- Hepatic enzymes (GGT, AST in horses; ALT in dogs)
Toxicity and overdose
Right dorsal colitis in horses (3–10 days into therapy): sudden colic, diarrhoea, hypoproteinaemia, ventral oedema. Mortality 50 %. Dogs: GI ulceration, hepatic toxicity, bone marrow suppression. Carcinogenic in humans (agranulocytosis, aplastic anaemia) — WEAR GLOVES when handling paste / powder.
Management: Stop drug. Sucralfate 1 g PO q6h (horse) or 0.5–1 g PO q8h (dog) for GI protection. Omeprazole 4 mg/kg PO q24h. IV crystalloid for renal protection. Plasma transfusion if severe hypoproteinaemia (right dorsal colitis). CBC monitoring for bone marrow recovery.
Clinical pearls
- Acute equine lameness: 4.4 mg/kg PO BID day 1 → 2.2 mg/kg PO BID days 2–4 — most horses respond, taper after acute phase
- NEVER combine bute with flunixin or another NSAID — right dorsal colitis risk multiplies
- Always pair chronic bute with omeprazole 4 mg/kg PO q24h for GI protection
- PROHIBITED in food animals in most jurisdictions — never give to a cow, sheep, or goat that may enter the food chain
- Dogs: phenylbutazone is largely obsolete — use carprofen / meloxicam / firocoxib instead
- Wear gloves with paste / powder — human aplastic anaemia is the reason this drug was pulled from human medicine
Mechanism of action
Non-selective COX-1 / COX-2 inhibitor — reduces prostaglandin synthesis → anti-inflammatory, analgesic, antipyretic. The COX-1 inhibition is the source of GI ulceration and renal papillary necrosis with chronic use. High plasma protein binding (~98 %) → displaces other protein-bound drugs.
Formulations and products
- Bute paste 12 g per 32 g tube (≈ 1 g/syringe-mark)
- Bute tablet 1 g
- Phenylbutazone injection 200 mg/mL (equine)
- Phenylbutazone oral powder 1 g per 10 g of powder (100 mg/g), mixed into feed (Phenylbute — Plumb’s p.965)
Storage
15–25 °C protected from light. Paste / powder: tightly closed. Multidose injection: discard 28 d after broaching.
Before you use this dose
Reference doses for veterinary professionals. Confirm the dose against the product label, the patient’s condition, current guidance and local regulations before use; the attending veterinarian remains responsible for every clinical decision.
Frequently asked questions
What is the dose of Phenylbutazone for dogs?
Reference doses for Phenylbutazone in dogs: 14 mg/kg PO q8h initial then taper (Pain / inflammation (Plumb's, historical)). Confirm against the label and the patient before use.
What is the dose of Phenylbutazone for cats?
Reference doses for Phenylbutazone in cats: 6–8 mg/kg PO q12h (Anti-inflammatory (rarely used)). Confirm against the label and the patient before use.
What is the dose of Phenylbutazone for horses?
Reference doses for Phenylbutazone in horses: 4.4 mg/kg PO q12h for 2–3 days, then taper (Acute lameness / inflammation); 2.2 mg/kg PO q12h, then q24h (Maintenance / chronic OA); 2.2–4.4 mg/kg IV q24h for 48–96 h (max 5 days) (IV therapy). Confirm against the label and the patient before use.
When should Phenylbutazone not be used?
PROHIBITED in any animal intended for human consumption (food animals — long tissue residence; carcinogenic concerns in humans). Pre-existing GI ulcers, hepatic / renal disease, bone marrow disorders. Hypersensitivity. Dehydration. Dogs: newer COX-2 selective NSAIDs preferred — bute is not recommended in dogs by current standard of care.
What are the side effects of Phenylbutazone in animals?
GI ulceration — right dorsal colitis in horses (most serious complication; sudden onset diarrhoea / colic / hypoproteinaemia); Renal papillary necrosis (especially with dehydration); Hepatic toxicity; Bone marrow suppression (long-term, dogs); Oral / oesophageal irritation from undissolved paste / powder; Hypoproteinaemia / oedema (chronic use).
Sources
- Plumb's Veterinary Drug Handbook
- Papich, Papich Handbook of Veterinary Drugs, 5th edition
Last reviewed · VetMasterJi